Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new ...
These are the kinds of stocks long-term investors will often be interested in, since they must have excellent, resilient ...
Speaking on today's call will be Rob Davis, chairman and chief executive officer; Caroline Litchfield, chief financial officer; and Dr. Dean Li, president of Merck Research Labs. Before we get ...
Dean Li, president of Merck Research Laboratories, told the meeting that cardiovascular disease is a big opportunity as it remains an epidemic, killing 35 million people during the pandemic while ...
On Tuesday, Merck & Co Inc (NYSE:MRK) reported fourth-quarter sales of $15.62 billion, up 7% year over year and slightly beating the consensus estimate of $15.49 billion. Excluding the impact of ...
Dr. Dean Li, President, Merck Research Laboratories, would no doubt disagree. In a webcast to analysts, Li noted that in 2024 more than 20 Phase 3 studies were initiated in multiple therapeutic areas.
Merck Research Laboratories. “We are grateful to the dedicated community of patients who participated in these studies and are pleased to offer the option of receiving WINREVAIR through the ...
VP of global clinical development at Merck Research Laboratories, said in a statement. Although the LEAP-015 readout is technically positive given the trial’s dual primary endpoint design ...
Merck Research Laboratories. Winrevair is currently approved in 38 countries including the U.S., based on the results from the Phase 3 STELLAR study. The views and opinions expressed herein are ...
Paula Annunziato, senior vice president, infectious diseases and vaccines, Global Clinical Development, Merck Research Laboratories, said, "Invasive pneumococcal disease can lead to serious ...
The healthcare pioneer shares insights on transformative diagnostics where precision medicine meets women’s health innovation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results